Stockholders' Equity - Narrative (Details)					1 Months Ended								12 Months Ended				26 Months Ended
	Mar. 18, 2021 shares	Jan. 01, 2021 shares	Aug. 04, 2020 USD ($) $ / shares shares	Nov. 08, 2019 Vote $ / shares shares	Jun. 30, 2021 USD ($) shares	Jan. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2020 shares	Jul. 31, 2020 USD ($) $ / shares shares	Jun. 30, 2020 $ / shares shares	May 31, 2020	Apr. 30, 2020 USD ($) $ / shares shares	Nov. 30, 2019 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Jul. 28, 2021 shares	Jul. 27, 2021 shares	Feb. 01, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock exchange ratio				1
Exchange of Class B Common Stock for Class A Common Stock (in shares)				3,480,466										13,218,758	18,167,547		31,936,305
Exchange of Class B Common Stock for Class A Common Stock | $														$ 77,900,000
Common stock, shares authorized (in shares)													300,000,000						300,000,000	245,000,000
Vote for each share | Vote				1
Share price (in dollars per share) | $ / shares			$ 18.7175
Proceeds from the issuance of Class A Common Stock | $													$ 0	278,850,000	$ 142,600,000
Offering costs | $													$ 0	$ 13,832,000	$ 11,725,000
Preferred Stock, par value (in dollars per share) | $ / shares													$ 0.0001	$ 0.0001			$ 0.0001	$ 0.0001
Preferred Stock, shares issued (in shares)													124,060
Authorized purchase amount | $													$ 200,000,000
Warrants outstanding (in shares)				12,666,666									3,871,557
Common stock for each warrant exercised (in shares)			0.3856	1
Exercise price (in dollars per share) | $ / shares			$ 11.50	$ 11.50
Warrants exercised in cashless transaction, number exercised (in shares)													184,870	224,121	6,254,803
Shares issued in cashless exercise of warrants (in shares)													87,553	118,379
Warrants exercised for cash, number exercised (in shares)															2,131,315
Proceeds from the exercise of warrants | $													$ 0	$ 0	$ 24,495,000
Warrant redemption price (in dollars per share) | $ / shares			0.01
Stock trigger price (in dollars per share) | $ / shares			$ 18.00
Threshold trading days (in trading days) | $			20
Threshold consecutive trading days (in trading days)			30 days
Warrant exercise price (in dollars per share)			0.6144
Price period (in trading days)			10 days
Public warrants, number redeemed (in shares)															2,285,410
Exercise of warrants (in shares)															881,239
Earn-out consideration, shares per annual installment (in shares)													1,000,000	1,000,000	1,000,000
Second stock price hurdle (in dollars per share) | $ / shares													$ 22	$ 18	$ 15
Issuance of shares in contingent consideration (in shares)													0	1,000,000	1,000,000
Remaining contingent consideration (in shares)														1,000,000
Increase (decrease) in deferred tax assets | $													$ 1,600,000	$ (1,600,000)			$ (1,600,000)	$ (1,600,000)
Granted (in shares)						703,170					47,335	3,416,666		703,000	47,000
Vesting period (in years)						3 years
Exercise period (in years)						5 years
Options granted, grant date fair value | $						$ 6,900,000					$ 300,000	$ 7,200,000
Options forfeited (in shares)													914,000
Granted (in dollars per share) | $ / shares											$ 16.25	$ 11.50		$ 48.72	$ 16.25
Options outstanding (in shares)													4,962,000	5,766,000	3,464,001	3,417,000	5,766,000	5,766,000
Number of shares issued for options exercised on a cash basis (in shares)													489,191	1,138,982	0
Exercise of options | $													$ 2,510,000	$ 12,320,000
Options exercised in cashless basis (in shares)													315,349	307,613
Options exercised cashless basis (in shares)													131,741	133,126
Equity-based compensation expense | $													$ 22,400,000	$ 25,300,000	$ 18,700,000
Excess tax benefits associated with equity-based compensation | $													2,100,000	4,600,000	2,100,000
Unrecognized compensation expense | $													$ 34,400,000
Recognition period (in years)													1 year 10 months 24 days
Noncontrolling interests in subsidiaries
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exchange of Class B Common Stock for Class A Common Stock | $														77,919,000	35,271,000
Treasury Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased under share repurchase program (in shares)													750,835
Value of repurchase | $													$ 14,000,000
Performance Percentage Less Than 25
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance payout percentage													0.00%
Performance Percentage Greater Than Or Equal To 25
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance payout percentage													50.00%
Performance Percentage Equal To 50
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance payout percentage													100.00%
Performance Percentage Greater Than Or Equal To 75
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance payout percentage													200.00%
General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense | $													$ 15,800,000	18,000,000	10,800,000
Cost of Sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense | $													$ 6,600,000	$ 7,300,000	$ 7,900,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise period (in years)												10 years
Options forfeited (in shares)														679,958
Accelerated vesting, number of shares (in shares)					184,932
Accelerated vesting cost | $					$ 1,900,000
Vested (in shares)													(722,222)	(722,222)	(1,154,667)
Unvested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)													962,000	1,354,000	2,120,000
Equity-based compensation expense | $														$ 500,000
Accelerated vesting (in shares)														22,192				22,192
Forfeited (in shares)													196,000	851,000	232,000			77,808
Vested (in shares)													(700,000)	(556,000)	(541,000)
Unvested restricted stock | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)															2,082,604
Grant date fair value | $															$ 38,700,000
Unvested restricted stock | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant date fair value | $															$ 800,000
Unvested restricted stock | Minimum | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)															3 years
Unvested restricted stock | Maximum | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)															4 years
Retention Program Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)														70,634	57,069
Equity-based compensation expense | $														$ 2,400,000	$ 1,100,000
Share-based Payment Arrangement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation expense | $														$ 1,500,000
Share-based Payment Arrangement | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)																1 year
Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options forfeited (in shares)														234,390
Various Employees | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)															1 year
Granted (in shares)															37,198
Various Employees | Unvested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)													562,686	1,266,846
Grant date fair value | $													$ 10,300,000	$ 37,100,000
Various Employees | Unvested restricted stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)													3 years	3 years
Various Employees | Unvested restricted stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)													4 years	4 years
Various Employees Non Employee Directors | Unvested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)													1 year	1 year
Granted (in shares)													81,347	87,500
Grant date fair value | $													$ 1,500,000	$ 2,000,000
Management | Performance Based Restricted Stock Unit
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)													3 years
Granted (in shares)													317,554
Grant date fair value | $													$ 8,700,000
Employee Of Acquired Entity | Unvested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)															300,000
Equity-based compensation expense | $															$ 3,900,000
Accelerated vesting (in shares)															50,000
Forfeited (in shares)															125,000
Vested (in shares)															(125,000)
Employee Of Acquired Entity | Unvested restricted stock | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)															50,000
Vesting percentage															25.00%
Employee Of Acquired Entity | Unvested restricted stock | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)															250,000
2019 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance (in shares)													10,000,000
Stock available for issuance (in shares)													2,191,908
Granted (in shares)														703,000	47,000
Options forfeited (in shares)														914,000
Granted (in dollars per share) | $ / shares														$ 48.72	$ 16.25
Options outstanding (in shares)													2,219,000	2,219,000	3,464,000	3,417,000	2,219,000	2,219,000
Grant date fair value | $																$ 4,500,000
2019 Incentive Plan | Share-based Payment Arrangement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)																4 years
Vesting percentage										25.00%
2019 Incentive Plan | Share-based Payment Arrangement | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage																50.00%
2019 Incentive Plan | Share-based Payment Arrangement | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage																50.00%
AeroCare
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price (in dollars per share) | $ / shares																					$ 6.24
Granted (in shares)														3,960,000
Granted (in dollars per share) | $ / shares														$ 6.24
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exchange of Class B Common Stock for Class A Common Stock (in shares)		13,218,758
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Series A Preferred Stock to Class A Common Stock (in shares)							2,887,709
Exchange of Class A Common Stock for Series B-1 Preferred Stock (in shares)									15,810,547
Conversion of Series B-1 Preferred Stock to Class A Common Stock (in shares)													0	3,950,000	2,000,000
Conversion Of Series C-1 Preferred Stock to Class A Common Stock (in shares)	13,047,473
Shares issued in cashless exercise of warrants (in shares)															1,973,707
Shares issued in cash exercise of warrants (in shares)															2,131,315
Preferred Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Series A Preferred Stock to Class A Common Stock (in shares)							39,706
Series B-2 Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, net of offering costs (in shares)								35,000
Proceeds from sale of stock | $								$ 35,000,000
Conversion of Series B-2 Preferred Stock to Series B-1 Preferred Stock (in shares)							35,000
Series B-1 Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Series B-2 Preferred Stock to Series B-1 Preferred Stock (in shares)							25,454.55
Exchange of Class A Common Stock for Series B-1 Preferred Stock (in shares)									158,105.47
Preferred Stock, par value (in dollars per share) | $ / shares									$ 0.0001
Preferred stock, liquidation preference (in dollars per share) | $ / shares									$ 0.0001
Shares of common stock received in conversion for each share of preferred stock (in shares)									100
Preferred stock conversion, ceiling as a percent of outstanding common stock									0.049
Conversion of Series B-1 Preferred Stock to Class A Common Stock (in shares)													0	39,500	20,000
Preferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock received in conversion for each share of preferred stock (in shares)	100
Conversion Of Series C-1 Preferred Stock to Class A Common Stock (in shares)	130,474.73
Preferred Stock | AeroCare
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, liquidation preference (in dollars per share) | $ / shares																					$ 0.0001
Preferred Stock, shares issued (in shares)																					130,474.73
Public Offering
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, net of offering costs (in shares)						8,450,000
Share price (in dollars per share) | $ / shares						$ 33.00
Proceeds from sale of stock | $						$ 278,900,000								$ 265,018,000	$ 132,514,000
Proceeds from the issuance of Class A Common Stock | $						265,000,000
Offering costs | $						$ 13,800,000								$ 13,832,000	10,086,000
Public Offering | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, net of offering costs (in shares)								9,200,000
Share price (in dollars per share) | $ / shares								$ 15.50
Proceeds from sale of stock | $								$ 142,600,000
Offering costs | $								10,100,000
Private Placement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from sale of stock | $								190,000,000							223,361,000
Offering costs | $								$ 1,600,000							$ 1,639,000
Private Placement | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, net of offering costs (in shares)								10,930,471
Private Placement | Preferred Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, net of offering costs (in shares)								39,706
Adapt Health Holdings LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Controlling interest, as a percent				56.00%
Adapt Health Holdings LLC | Shareholders of Adapt Health Holdings LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Noncontrolling interest, as a percent				44.00%
Number of votes per share | Vote				1